BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7934537)

  • 1. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
    Alonso PL; Smith T; Schellenberg JR; Masanja H; Mwankusye S; Urassa H; Bastos de Azevedo I; Chongela J; Kobero S; Menendez C
    Lancet; 1994 Oct; 344(8931):1175-81. PubMed ID: 7934537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
    D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
    Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
    Nosten F; Luxemburger C; Kyle DE; Ballou WR; Wittes J; Wah E; Chongsuphajaisiddhi T; Gordon DM; White NJ; Sadoff JC; Heppner DG
    Lancet; 1996 Sep; 348(9029):701-7. PubMed ID: 8806288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
    Galindo CM; Acosta CJ; Schellenberg D; Aponte JJ; Roca A; Oettli A; Urassa H; Armstrong Schellenberg J; Kahigwa E; Ascaso C; Mshinda H; Lwilla F; Vidal J; Menendez C; Tanner M; Alonso PL
    Parasite Immunol; 2000 Sep; 22(9):437-43. PubMed ID: 10972850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.
    Valero MV; Amador LR; Galindo C; Figueroa J; Bello MS; Murillo LA; Mora AL; Patarroyo G; Rocha CL; Rojas M
    Lancet; 1993 Mar; 341(8847):705-10. PubMed ID: 8095622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum.
    Alonso PL; Smith TA; Armstrong-Schellenberg JR; Kitua AY; Masanja H; Hayes R; Hurt N; Font F; Menendez C; Kilama WL; Tanner M
    J Infect Dis; 1996 Aug; 174(2):367-72. PubMed ID: 8699068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
    Alonzo PL; Smith T; Schellenberg JR; Masanja H; Mwankusye S; Urassa H; Bastos De Azevedo I; Chongela J; Kobero S; Menendez C
    Med Trop (Mars); 1995; 55(4 Suppl):41-6. PubMed ID: 8649265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An efficacy trial of a malaria vaccine in Gambian infants and comparison with insecticide-treated bednets.
    D'Alessandro U
    Ann Trop Med Parasitol; 1996 Aug; 90(4):373-8. PubMed ID: 8944081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador.
    Sempértegui F; Estrella B; Moscoso J; Piedrahita L; Hernández D; Gaybor J; Naranjo P; Mancero O; Arias S; Bernal R
    Vaccine; 1994 Mar; 12(4):337-42. PubMed ID: 8178556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania.
    Acosta CJ; Galindo CM; Schellenberg D; Aponte JJ; Kahigwa E; Urassa H; Schellenberg JR; Masanja H; Hayes R; Kitua AY; Lwilla F; Mshinda H; Menendez C; Tanner M; Alonso PL
    Trop Med Int Health; 1999 May; 4(5):368-76. PubMed ID: 10402973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of SPf66 malaria vaccine efficacy in Brazil.
    Urdaneta M; Prata A; Struchiner CJ; Tosta CE; Tauil P; Boulos M
    Am J Trop Med Hyg; 1998 Mar; 58(3):378-85. PubMed ID: 9546423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission.
    Teuscher T; Schellenberg JR; Bastos de Azevedo I; Hurt N; Smith T; Hayes R; Masanja H; Silva Y; Lopez MC; Kitua A
    Vaccine; 1994 Mar; 12(4):328-36. PubMed ID: 8178555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.
    Haywood M; Conway DJ; Weiss H; Metzger W; D'Alessandro U; Snounou G; Targett G; Greenwood B
    Trans R Soc Trop Med Hyg; 1999 Feb; 93 Suppl 1():65-8. PubMed ID: 10450429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
    Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B
    Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2003; (1):CD000129. PubMed ID: 12535387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological responses of Gambian children to immunization with the malaria vaccine SPf66.
    Metzger WG; Haywood M; D'Alessandro U; Drakeley CJ; Weiss H; Bojang K; Targett GA; Greenwood BM
    Parasite Immunol; 1999 Jul; 21(7):335-40. PubMed ID: 10417667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2000; (2):CD000129. PubMed ID: 10796492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2007 Jul; 2003(4):CD000129. PubMed ID: 17636596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela.
    Noya O; Gabaldón Berti Y; Alarcón de Noya B; Borges R; Zerpa N; Urbáez JD; Madonna A; Garrido E; Jimenéz MA; Borges RE
    J Infect Dis; 1994 Aug; 170(2):396-402. PubMed ID: 8035026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.
    Alonso PL; Sacarlal J; Aponte JJ; Leach A; Macete E; Milman J; Mandomando I; Spiessens B; Guinovart C; Espasa M; Bassat Q; Aide P; Ofori-Anyinam O; Navia MM; Corachan S; Ceuppens M; Dubois MC; Demoitié MA; Dubovsky F; Menéndez C; Tornieporth N; Ballou WR; Thompson R; Cohen J
    Lancet; 2004 Oct 16-22; 364(9443):1411-20. PubMed ID: 15488216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.